OUTLOOK THERAPEUTICS, INC. Investing Cash Flow
OUTLOOK THERAPEUTICS, INC. (OTLK) reported Investing Cash Flow of -$2.10 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-18.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-18
- OUTLOOK THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2020-09-30 was $0.00.
- OUTLOOK THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2019-09-30 was -$1.00.
- OUTLOOK THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2019-06-30 was -$150.74K.
- OUTLOOK THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2019-03-31 was -$50.14K.
- OUTLOOK THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2020 was -$900.00K.
- OUTLOOK THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2019 was -$437.31K.
- OUTLOOK THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2018 was -$2.78M.
- OUTLOOK THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2017 was -$292.09K.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$2.10M 10-Q · filed 2026-08-18 | |||
| 2020-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-23 | -$900.00K 10-K · filed 2021-12-23 | ||
| 2020-06-30 | -$900.00K 10-Q · filed 2021-08-13 | |||
| 2019-09-30 | -$1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-23 | -$150.74K derived: sum of 2 quarters · filed 2020-12-23 | -$200.87K derived: sum of 3 quarters · filed 2020-12-23 | -$437.31K 10-K · filed 2020-12-23 |
| 2019-06-30 | -$150.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-14 | -$200.87K derived: sum of 2 quarters · filed 2020-08-14 | -$437.31K 10-Q · filed 2020-08-14 | -$1.70M derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | -$50.14K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-15 | -$286.57K 10-Q · filed 2020-05-15 | -$1.55M derived: sum of 3 quarters · filed 2020-05-15 | -$1.72M derived: sum of 4 quarters · filed 2020-05-15 |
| 2018-12-31 | -$236.43K 10-Q · filed 2020-02-14 | -$1.50M derived: sum of 2 quarters · filed 2020-02-14 | -$1.67M derived: sum of 3 quarters · filed 2020-02-14 | -$1.94M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-09-30 | -$1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-19 | -$1.43M derived: sum of 2 quarters · filed 2019-12-19 | -$1.71M derived: sum of 3 quarters · filed 2019-12-19 | -$2.78M 10-K · filed 2019-12-19 |
| 2018-06-30 | -$168.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-14 | -$443.21K derived: sum of 2 quarters · filed 2019-08-14 | -$1.52M 10-Q · filed 2019-08-14 | -$1.54M derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | -$275.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-15 | -$1.35M 10-Q · filed 2019-05-15 | -$1.37M derived: sum of 3 quarters · filed 2019-05-15 | |
| 2017-12-31 | -$1.08M 10-Q · filed 2019-02-14 | -$1.10M derived: sum of 2 quarters · filed 2019-02-14 | ||
| 2017-09-30 | -$23.98K derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-18 | -$292.09K 10-K · filed 2018-12-18 | ||
| 2017-06-30 | -$268.11K 10-Q · filed 2018-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |